Oxybenzone (Benzophenone-3) & Octinoxate
What published research says about Oxybenzone (Benzophenone-3) & Octinoxate, who paid for it, what replaced it, and what is measured in people. Every number links to its source.
Open in AbouitCheck a labelLive research
Newest published 2026-10-23 · counted 2026-11-05 · Europe PMC, title and abstract.
| Who paid for the 37 newest papers | Papers |
|---|---|
| Independent (public, academic, charity) | 21 |
| Industry | 1 |
| Mixed | 0 |
| None declared | 0 |
| Unclear | 15 |
Reported an effect: independent papers 15 of 21; industry-paid papers 0 of 1. Industry-paid does not mean wrong, and independent does not mean right. This is who paid, side by side.
Every paper, with its funding phrase and where it was read (JSON)
Measured in people’s bodies
| Substance | Survey | People tested | Detected in |
|---|---|---|---|
| Oxybenzone (benzophenone-3) | 2017–2018 | 2,759 | 98% |
US CDC NHANES, urine, weighted to the US population aged 6+. Point estimates; not adjusted for urine dilution. A level shows exposure, not harm. CDC data · JSON
From science to rules
- 1991 · By 1991, contact and photocontact allergy to oxybenzone was reported. Contact Dermatitis, 1991
- 2022-07-07 · EU lowers benzophenone-3 limits in cosmetics: 6% face, hand and lip products; 2.2% body products; 0.5% others. Regulation (EU) 2022/1176
Only events read at their source. JSON
Identity
PubChem CID 4632 · Label names: BENZOPHENONE-3, OXYBENZONE, ETHYLHEXYL METHOXYCINNAMATE, OCTINOXATE